×
验证码:
换一张
Forgotten Password?
Stay signed in
Login With UMPASS
English
|
繁體
Login With UMPASS
Log In
ALL
ORCID
TI
AU
PY
SU
KW
TY
JN
DA
IN
PB
FP
ST
SM
Study Hall
Home
Faculties & Institutes
Scholars
Publications
Subjects
Statistics
News
Search in the results
Faculties & Institutes
Institute of Chi... [1]
Faculty of Healt... [1]
THE STATE KEY LA... [1]
Authors
CHEN XIUPING [1]
LU JIAHONG [1]
MIAO KAI [1]
Document Type
Journal article [1]
Date Issued
2022 [1]
Language
英語English [1]
Source Publication
Chinese Medicine [1]
Indexed By
SCIE [1]
Funding Organization
Funding Project
×
Knowledge Map
UM
Start a Submission
Submissions
Unclaimed
Claimed
Attach Fulltext
Bookmarks
Browse/Search Results:
1-1 of 1
Help
Selected(
0
)
Clear
Items/Page:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Sort:
Select
Issue Date Ascending
Issue Date Descending
Author Ascending
Author Descending
Journal Impact Factor Ascending
Journal Impact Factor Descending
Title Ascending
Title Descending
Submit date Ascending
Submit date Descending
WOS Cited Times Ascending
WOS Cited Times Descending
Toosendanin, a late-stage autophagy inhibitor, sensitizes triple-negative breast cancer to irinotecan chemotherapy
Journal article
Zhang, Shuang, Dong, Yu, Chen, Xiuping, Tan, Chris Soon Heng, Li, Min, Miao, Kai, Lu, Jia Hong. Toosendanin, a late-stage autophagy inhibitor, sensitizes triple-negative breast cancer to irinotecan chemotherapy[J]. Chinese Medicine, 2022, 17, 55.
Authors:
Zhang, Shuang
;
Dong, Yu
;
Chen, Xiuping
;
Tan, Chris Soon Heng
;
Li, Min
; et al.
Favorite
|
TC[WOS]:
12
TC[Scopus]:
13
IF:
5.3
/
5.5
|
Submit date：2022/05/31
Apoptosis
Autophagy Inhibition
Irinotecan
Lysosome
Sn-38
Toosendanin
Triple-negative Breast Cancer
